BACKGROUND: Colorectal cancer is common worldwide and chemoprevention has the potential of reducing the number of individuals who may suffer and perish from this disease. METHODS: A randomized placebo controlled pilot study in colorectal cancer patients was performed using calcium carbonate as the test agent in a multi-institutional oncology study group. RESULTS:Two hundred twenty volunteers were randomized in the study. The primary goals of compliance, accrual, and toxicity monitoring are presented. Presence of multiple adenomas at study entry and subsequent development of metachronous adenomas were recorded and found to be associated with synchronous adenomas. The secondary endpoint of recurrent adenomas indicated lower rates of new adenoma in the volunteers randomized to the calcium group. CONCLUSION: This pilot study indicates the feasibility of enrolling survivors of colorectal cancer as study volunteers in a colorectal neoplasm chemoprevention clinical trial and oral calcium continues to be a potentially effective drug in reducing colorectal adenomas.
RCT Entities:
BACKGROUND:Colorectal cancer is common worldwide and chemoprevention has the potential of reducing the number of individuals who may suffer and perish from this disease. METHODS: A randomized placebo controlled pilot study in colorectal cancerpatients was performed using calcium carbonate as the test agent in a multi-institutional oncology study group. RESULTS: Two hundred twenty volunteers were randomized in the study. The primary goals of compliance, accrual, and toxicity monitoring are presented. Presence of multiple adenomas at study entry and subsequent development of metachronous adenomas were recorded and found to be associated with synchronous adenomas. The secondary endpoint of recurrent adenomas indicated lower rates of new adenoma in the volunteers randomized to the calcium group. CONCLUSION: This pilot study indicates the feasibility of enrolling survivors of colorectal cancer as study volunteers in a colorectal neoplasm chemoprevention clinical trial and oral calcium continues to be a potentially effective drug in reducing colorectal adenomas.
Authors: Robert S Sandler; Susan Halabi; John A Baron; Susan Budinger; Electra Paskett; Roger Keresztes; Nicholas Petrelli; J Marc Pipas; Daniel D Karp; Charles L Loprinzi; Gideon Steinbach; Richard Schilsky Journal: N Engl J Med Date: 2003-03-06 Impact factor: 91.245
Authors: Michelle D Holmes; Wendy Y Chen; Lisa Li; Ellen Hertzmark; Donna Spiegelman; Susan E Hankinson Journal: J Clin Oncol Date: 2010-02-16 Impact factor: 44.544
Authors: Kristin Wallace; John A Baron; Bernard F Cole; Robert S Sandler; Margaret R Karagas; Michael A Beach; Robert W Haile; Carol A Burke; Loretta H Pearson; Jack S Mandel; Richard Rothstein; Dale C Snover Journal: J Natl Cancer Inst Date: 2004-06-16 Impact factor: 13.506
Authors: Rowan T Chlebowski; Jean Wactawski-Wende; Cheryl Ritenbaugh; F Allan Hubbell; Joao Ascensao; Rebecca J Rodabough; Carol A Rosenberg; Victoria M Taylor; Randall Harris; Chu Chen; Lucile L Adams-Campbell; Emily White Journal: N Engl J Med Date: 2004-03-04 Impact factor: 91.245
Authors: David Z J Chu; Kari Chansky; David S Alberts; Frank L Meyskens; Cecilia M Fenoglio-Preiser; Saul E Rivkin; Glenn M Mills; Jeffrey K Giguere; Gary E Goodman; James L Abbruzzese; Scott M Lippman Journal: Ann Surg Oncol Date: 2003-10 Impact factor: 5.344
Authors: John A Baron; Elizabeth L Barry; Leila A Mott; Judy R Rees; Robert S Sandler; Dale C Snover; Roberd M Bostick; Anastasia Ivanova; Bernard F Cole; Dennis J Ahnen; Gerald J Beck; Robert S Bresalier; Carol A Burke; Timothy R Church; Marcia Cruz-Correa; Jane C Figueiredo; Michael Goodman; Adam S Kim; Douglas J Robertson; Richard Rothstein; Aasma Shaukat; March E Seabrook; Robert W Summers Journal: N Engl J Med Date: 2015-10-15 Impact factor: 91.245
Authors: Audrey H Calderwood; John A Baron; Leila A Mott; Dennis J Ahnen; Roberd M Bostick; Jane C Figueiredo; Michael N Passarelli; Judy R Rees; Douglas J Robertson; Elizabeth L Barry Journal: Cancer Prev Res (Phila) Date: 2019-03-04
Authors: Payam Hosseinzadeh; Mohammad Javanbakht; Mahdi Alemrajabi; Ali Gholami; Bahare Amirkalali; Masoudreza Sohrabi; Farhad Zamani Journal: Asian Pac J Cancer Prev Date: 2019-09-01
Authors: Parambir S Dulai; Siddharth Singh; Evelyn Marquez; Rohan Khera; Larry J Prokop; Paul J Limburg; Samir Gupta; Mohammad Hassan Murad Journal: BMJ Date: 2016-12-05